Table 9 Recommendations for CMR in the context of myocardial revascularization

Recommendations for imaging to determine ischemia to plan revascularization

Class^a

Level^b

Page

 Stress CMR, stress-echo, SPECT or PET are recommended in subjects with intermediate pretest probability for suspected coronary artery disease and stable symptoms

I

A

14

 To achieve a prognostic benefit by revascularization in patients with coronary artery disease, ischemia has to be documented by non-invasive imaging

 Left main disease with stenosis >50 %

I

A

18

 Any proximal LAD stenosis >50 %

I

A

18

 Two-vessel or three-vessel disease with stenosis > 50 % with impaired LV function (LVEF < 40 %)a

I

A

18

 Large area of ischaemia (>10 % LV)

I

B

18

 Single remaining patent coronary artery with stenosis >50 %

I

C

18

Recommendations for follow-up and management after myocardial revascularization for asymptomatic patients

Class^a

Level^b

Page

 Early imaging testing should be considered in specific patient subsets.

IIa

C

72

 Routine stress testing may be considered >2 years after PCI and >5 years after CABG.

IIa

B

72

Recommendations for follow-up and management after myocardial revascularization for symptomatic patients

Class^a

Level^b

Page

 It is recommended to reinforce medical therapy and lifestyle changes in patients with low-risk findings at stress testing.

I

C

72

 With intermediate- to high-risk findings at stress testing, coronary angiography is recommended.

I

C

72

Recommendation for carotid artery screening before CABG

Class^a

Level^b

Page

 CMR, CT, or digital subtraction angiography may be considered if carotid artery stenosis by ultrasound is >70 % and myocardial revascularization is contemplated.

IIb

C

39